Nasal Spray Market Share 2021 Growth Challenges, Opportunities and Future Trends 2027
The global nasal spray market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Nasal spray is a liquid form of concentrated medicine that is dispensed through a compact container/bottle into the nose for the treatment of the nasal congestion problem. The active ingredient's intended action can be local or systemic in nature. Nasal spray sprays are designed to be deposited in the nasal or pharyngeal region. The rising prevalence of asthma and COPD, as well as the low cost of these sprays are propelling the market growth. Asthma is the most common chronic condition among children globally, as per the World Health Organization (WHO) research published in 2019. Asthma affected around 235 million people across the globe in 2019. Low- and lower-middle-income nations account for more than 80% of asthma-related mortalities.
The risk factor for developing
asthma includes inhaled substances and particles that create allergic reactions
or irritate the airways whereas risk factor leading to the cause of COPD
includes tobacco smoke or second-hand smoke, exposure to indoor or outdoor air
pollution, dusts and fumes, and long-term asthma. Furthermore, as per the
study conducted by National Health and Planning Commission in 2019, 30 million
people in China suffered from asthma and only 28% of the people with asthma
have their condition under control. This, in turn, is driving the demand for
nasal sprays for the management of asthma and COPD.
To Request a Sample of our Report on Nasal Spray Market: https://www.omrglobal.com/request-sample/nasal-spray-market
Some key players operating in the
market include AstraZeneca plc, Novartis International AG, and Teva
Pharmaceutical Industries Ltd., among others. These players are eyeing on
strengthening their position in the market by adopting various strategies as
mergers and acquisitions, partnerships, collaborations, new product launch and
development in the existing product portfolio, and so on. For instance, in
February 2022, Glenmark Ltd. and Canadian biotech firm SaNOtize Research and
Development Corp launched its Nitric Oxide Nasal Spray (NONS) under the brand
name FabiSpray in India. It can be used for the treatment of adult patients
with COVID-19 who have a high risk of progression of the disease.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
Segment Covered-
•
By Product
•
By Application
Regions covered-
•
North America
•
Europe
•
Asia-Pacific
•
Rest of the World
Competitive Landscape:
AstraZeneca plc, Novartis International AG, and Teva Pharmaceutical Industries
Ltd., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Nasal Spray Market is Available @ https://www.omrglobal.com/industry-reports/nasal-spray-market
Global Nasal Spray Market Report by Segment
By Product
• Bronchodilators
• Corticosteroids
• Combination
• Decongestant
• Others
By Application
•
Asthma
•
COPD
•
Allergic Rhinitis
•
Others
Global Nasal Spray Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment